Targeting protein modification: a new direction for immunotherapy of pancreatic cancer

被引：0
|
作者：
Ge, Xinyu [1 ]
Zhang, Ke [2 ]
Zhu, Jie [1 ]
Chen, Yuan [1 ]
Wang, Zhengwang [1 ]
Wang, Peng [1 ]
Xu, Peng [1 ]
Yao, Jie [1 ]
机构：
[1] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Yangzhou 225000, Jiangsu, Peoples R China
[2] Dalian Med Univ, Yangzhou Sch Clin Med, Yangzhou 225000, Jiangsu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2025年 / 21卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Post-translational modifications; Immunotherapy; Targeted therapy; Immune escape; Pancreatic cancer; PD-L1; EXPRESSION; AUGMENTS IMMUNOTHERAPY; ACTIVATION; INHIBITION; PHOSPHORYLATION; GLYCOSYLATION; PATHWAY; GROWTH; CELLS; SUMO;
D O I：
10.7150/ijbs.101861
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Post-translational modifications (PTMs) alter protein conformation by covalently attaching functional groups to substrates, influencing their biological activity, mechanisms of action, and functional performance. PTMs and their interactions are essential to many critical signal transduction processes, including tumor transformation, cancer progression, and metastasis in pancreatic cancer. Additionally, advancements in tumor immunotherapy indicate that PTMs are essential in immune cell activation, transport, and energy metabolism. This study aimed to investigate the effects of different PTMs on immunotherapy for pancreatic cancer, providing new perspectives and suggesting directions for future research.
引用
收藏
页码：63 / 74
页数：12
相关论文
共 50 条
  • [31] Immunotherapy for pancreatic cancer
    Kotteas, Elias
    Saif, Muhammad Wasif
    Syrigos, Konstantinos
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (08) : 1795 - 1805
  • [32] Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
    Zhou, Wenxi
    Zhou, Yu
    Chen, Xinli
    Ning, Tingting
    Chen, Hongyi
    Guo, Qin
    Zhang, Yiwen
    Liu, Peixin
    Zhang, Yujie
    Li, Chao
    Chu, Yongchao
    Sun, Tao
    Jiang, Chen
    BIOMATERIALS, 2021, 268
  • [33] Targeting vasoactive intestinal peptide signaling to enhance pancreatic cancer responsiveness to immunotherapy
    Ravindranathan, Sruthi
    Li, Yiwen
    Wang, Shuhua
    Zaidi, Mohammad Y.
    Lesinski, Gregory B.
    El-Rayes, Bassel
    Waller, Edmund K.
    CANCER RESEARCH, 2019, 79 (13)
  • [34] Advances in pancreatic cancer immunotherapy for targeting programmed death-ligand 1
    Jiang, Haitao
    Fan, Xiaoxiang
    ASIAN JOURNAL OF SURGERY, 2023, 46 (06) : 2378 - 2379
  • [35] The NKG2A immune checkpoint — a new direction in cancer immunotherapy
    Benjamin C. Creelan
    Scott J. Antonia
    Nature Reviews Clinical Oncology, 2019, 16 : 277 - 278
  • [36] The NKG2A immune checkpoint - a new direction in cancer immunotherapy
    Creelan, Benjamin C.
    Antonia, Scott J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (05) : 277 - 278
  • [37] Targeting KRAS in pancreatic cancer: new drugs on the horizon
    Sahar F. Bannoura
    Md. Hafiz Uddin
    Misako Nagasaka
    Farzeen Fazili
    Mohammed Najeeb Al-Hallak
    Philip A. Philip
    Bassel El-Rayes
    Asfar S. Azmi
    Cancer and Metastasis Reviews, 2021, 40 : 819 - 835
  • [38] Targeting KRAS in pancreatic cancer: new drugs on the horizon
    Bannoura, Sahar F.
    Uddin, Md. Hafiz
    Nagasaka, Misako
    Fazili, Farzeen
    Al-Hallak, Mohammed Najeeb
    Philip, Philip A.
    El-Rayes, Bassel
    Azmi, Asfar S.
    CANCER AND METASTASIS REVIEWS, 2021, 40 (03) : 819 - 835
  • [39] Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?
    Wirth, Thomas C.
    Kuehnel, Florian
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [40] New strategies for cancer immunotherapy: targeting regulatory T cells
    Francesca Finotello
    Zlatko Trajanoski
    Genome Medicine, 9
12345